ChartMill · Jul 24, 2026
On Friday, there are stocks with unusual volume. Let's take a look.
In today's session, there are stocks attracting attention with their unusual volume. Let's take a closer look.
NASDAQ · ADVB
Healthcare · Medical - Diagnostics & Research
$6.38
Up+$0.04 (+0.63%)
Updated Oct 7, 2026, 11:23 AM
SID Score
4.1/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · ADVB
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 6, 2026
ADVB closed at $6.38 after 21 trading sessions, down 28.95% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 6, 2026 | $6.39 | $6.74 | $6.38 | $6.38 | 15.43K |
| Oct 5, 2026 | $6.60 | $7.03 | $6.34 | $6.34 | 15.08K |
| Oct 2, 2026 | $6.97 | $7.05 | $6.50 | $6.73 | 27.06K |
| Oct 1, 2026 | $6.24 | $7.12 | $6.24 | $6.91 | 20.12K |
| Sep 30, 2026 | $6.37 | $6.48 | $6.23 | $6.23 | 14.89K |
| Sep 29, 2026 | $6.62 | $6.74 | $6.31 | $6.32 | 19.57K |
| Sep 28, 2026 | $6.67 | $7.23 | $6.59 | $6.73 | 43.22K |
| Sep 25, 2026 | $6.31 | $6.685 | $6.31 | $6.38 | 13.67K |
| Sep 24, 2026 | $6.35 | $6.54 | $6.31 | $6.31 | 8.88K |
| Sep 23, 2026 | $6.41 | $6.70 | $6.31 | $6.32 | 12.35K |
| Sep 22, 2026 | $6.53 | $6.77 | $6.38 | $6.38 | 12.4K |
| Sep 21, 2026 | $6.61 | $6.6899 | $6.28 | $6.47 | 19.65K |
| Sep 18, 2026 | $7.32 | $7.47 | $6.26 | $6.54 | 59.54K |
| Sep 17, 2026 | $7.76 | $8.00 | $7.232 | $7.32 | 34.07K |
| Sep 16, 2026 | $7.94 | $8.14 | $7.72 | $7.72 | 13.38K |
| Sep 15, 2026 | $7.75 | $8.2096 | $7.4136 | $8.08 | 15.24K |
| Sep 14, 2026 | $8.21 | $8.37 | $7.54 | $7.78 | 23.98K |
| Sep 11, 2026 | $8.87 | $8.87 | $7.90 | $8.19 | 92.2K |
| Sep 10, 2026 | $8.29 | $9.0848 | $8.29 | $8.85 | 121.15K |
| Sep 9, 2026 | $8.84 | $9.04 | $8.38 | $8.50 | 84.74K |
| Sep 8, 2026 | $9.29 | $9.37 | $8.65 | $8.98 | 39.86K |
The latest Smart Investors Daily articles mentioning ADVB.
Company
Market Activity
Research & News
ADVB research
Company profile and research snapshot.
Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.
Visit company websiteConsensus and target data currently published for this company.
No generated briefing is available yet.
ChartMill · Jul 24, 2026
In today's session, there are stocks attracting attention with their unusual volume. Let's take a closer look.
Benzinga · Jul 24, 2026
Gainers Advanced Biomed (NASDAQ:ADVB) shares moved upwards by 28.3% to $21.53 during Friday's pre-market session. The company's market cap stands at $27.4 million. Akanda (NASDAQ:AKAN) shares increased by
ChartMill · Jul 21, 2026
Discover the stocks with unexpected trading volume in today's session on the US markets.
Benzinga · Jul 21, 2026
Advanced Biomed stock surges after withdrawing its SEC Form S-1, removing a planned securities offering and potential shareholder dilution.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning ADVB.